Uni-flo2 Single-nasal Cannula System (Uni-flo2), a breakthrough patient-centric solution that ensures continuous oxygen flow equivalent to the low flow dual-pronged cannula but with half the skin contact, announces the release of its white paper, “Breathe Easier: Single-Prong Cannula Represents Important Breakthrough in Oxygen Therapy for COPD Patients.”
LEHIGH VALLEY, PA – August 13, 2018 –Uni-flo2 Single-nasal Cannula System (Uni-flo2), a breakthrough patient-centric solution that ensures continuous oxygen flow equivalent to the low flow dual-pronged cannula but with half the skin contact, announces the release of its white paper, “Breathe Easier: Single-Prong Cannula Represents Important Breakthrough in Oxygen Therapy for COPD Patients.” Authored by Campbell Cauthen, Registered Respiratory Therapist and co-inventor, Uni-flo2, the paper articulates issues related to the method of delivery of oxygen in supplemental oxygen therapy and highlights the advantages of a breakthrough redesign of the nasal cannula delivery system-- a single-prong nasal cannula -- for people living with COPD.
“With the vast number of COPD patients struggling to breathe and requiring low flow supplemental oxygen, the introduction of the discreet, lightweight Uni-flo2Single-nasal Cannula System (Uni-flo2) is a welcome life-changing experience that addresses the majority of the concerns expressed by long term dual nasal prong cannula users,” says Cauthen. “Half the weight, half the skin contact, and twice as discreet, the Uni-flo2conforms to all facial contours and ensures continuous low flow oxygen availability and maximizes patient comfort.”
Among the advantages of the Uni-flo2most frequently cited by surveyed COPD patients are:
- Greater comfort
- Freedom of movement
- Avoidance of facial skin irritation
- Improved sleep
- Ease of eating
- Enhanced ability to smell fragrances and food
- Enhanced personal appearance
“For those who are dependent on oxygen, the Uni-flo2, single nasal cannula provides a safe, secure, easy to use, and discreet device,”Cauthen adds. “Not only is it more comfortable and visually attractive than dual-prongedcannulas, it provides equivalent oxygen delivery and reduces the negative effects caused by long term use of the dual prong cannula.”
About Uni-flo2
Developed, manufactured and distributed by UPODS LLC., the Uni-flo2 Single Nasal Cannula is lightweight, eliminates half the skin contact and opportunity for infection, and improves patient freedom of movement, comfort, eating, sleeping and personal appearance. Uni-flo2 conforms to all facial contours with a strain relief system that ensures continuous low flow oxygen flow equivalent to the dual-pronged cannula. Designed with patient dignity, comfort and safety in mind for home care specialists, clinicians, assisted living facilities, hospitals and other healthcare providers. Uni-flo2 holds Patent No. 9,440,039 and Patent No. 9,925,348. Visit www.uniflo2.com.
Media:
Brittany Tedesco
CPR Communications for Uni-flo2
btedesco@cpronline.com
201.641.1911 x 14
